ArticleClinical immunology (Orlando, Fla.)2015

Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant.

Bala Vamsi K Karuturi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.